Business Wire
-
Thermo Fisher Scientific Launches The Krios 5 Cryo-Transmission Electron Microscope (TEM), Boosting Productivity And Performance With Enhanced Automation
4/2/2025
Thermo Fisher Scientific, the world leader in serving science, has introduced the Thermo Scientific Krios 5 Cryo-TEM.
-
Aditxt Subsidiary Pearsanta Completes The Acquisition Of Proprietary Adductomics Technology To Develop And Advance The Platform Toward Clinical And Commercial Applications For Monitoring Early Signs Of Increased Cancer Risk
3/24/2025
Aditxt, Inc. ("Aditxt" or the "Company"), a social innovation platform accelerating promising health innovations, today announced that its subsidiary, Pearsanta, Inc. ("Pearsanta"), has acquired key patents related to adductomics-based DNA damage detection, which it believes will further strengthen its position in the cancer prevention-focused diagnostic industry.
-
Techcyte Unveils Fusion, The First Unified Anatomic And Clinical Digital Pathology Platform
3/24/2025
Techcyte, a leader in AI-powered digital pathology, announced the launch of Fusion, the first open, standards-based, SaaS platform designed to unify anatomic and clinical pathology workflows.
-
Revvity Expands Alliance With Genomics England To Drive Research Into Newborn Genomic Sequencing In England
3/20/2025
Revvity, Inc. today announced an agreement with Genomics England to further collaborate on the Generation Study. Under the new contract, Revvity will now also provide DNA sequencing services to help screen newborns for rare genetic conditions.
-
GE HealthCare Expands Invasive Cardiology Solutions Portfolio With AltiX AI.i For Elevated Experience In Catheterization Lab And Electrophysiology Procedures
3/17/2025
GE HealthCare today announced the launch of the AltiX AI.i edition of Mac-Lab, CardioLab and ComboLab.
-
Guardant Health Receives ADLT Status From CMS For Shield Blood Test
3/11/2025
Guardant Health, Inc. a leading precision oncology company, today announced the Centers for Medicare & Medicaid Services (CMS) has approved Advanced Diagnostic Laboratory Test (ADLT) status for the Shield blood test for colorectal cancer (CRC) screening.
-
Pramana And ARUP Laboratories Partner To Digitize Pathology Slides And Develop AI-Powered Hematopathology Algorithms For Deployment Via Edge AI
3/11/2025
Pramana, Inc., an AI-enabled health tech company modernizing the pathology sector, and ARUP Laboratories, the largest nonprofit clinical and academic reference laboratory in the United States, announced a collaboration to digitize pathology slides and develop AI-powered algorithms to improve the assessment of bone marrow biopsies and address other key diagnostic challenges in hematopathology.
-
QuidelOrtho Introduces Results Manager System
3/10/2025
QuidelOrtho Corporation (“QuidelOrtho”) announces the availability of the QuidelOrtho Results Manager System, an informatics solution designed to address the growing demands of modern laboratories.
-
Savara Announces U.S. Launch Of The aPAP ClearPath Dried Blood Spot Test To Detect Autoimmune Pulmonary Alveolar Proteinosis (aPAP)
3/6/2025
Savara Inc. (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, announced the launch of the aPAP ClearPath Dried Blood Spot (DBS) Test in the U.S., an evolution of the first serum-based assay the Company launched.
-
Epredia Receives U.S. FDA 510(K) Clearance For The E1000 Dx Digital Pathology Solution Designed To Improve Laboratory Workflow In Cancer Diagnostics
3/4/2025
Epredia, a global leader in precision cancer diagnostics and subsidiary of PHC Holdings Corporation today announced U.S. Food and Drug Administration (FDA) 510(K) clearance for its E1000 Dx Digital Pathology Solution (E1000 Dx).